An improved process for the preparation of 2-arylthiazole derivatives
WO2012052829A1
Synthesis of aliskiren
WO2012032541A1
"adefovir dipivoxil pseudopolymorph"
CA2818895A1
Process for the preparation of (3r, 3as, 6ar)-hexahydrofuro [2,3-b] furan-3-ol
WO2011158259A1
Novel process for the preparation of (3s)-tetrahydrofuran-3-yl (is, 2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) propylcarbamate and its pharmaceutically acceptable salts thereof
WO2011158252A1
Process for the preparation of valacyclovir hydrochloride polymorphic form ii
WO2011141934A1
An improved process for the preparation of an intermediate of hmg-coa reductase inhibitors
WO2012056468A1
A process for the preparation of bosentan
WO2011095987A1
Novel process for the preparation of cis-nucleoside derivative
WO2011074016A1
Novel polymorphic forms of rosuvastatin calcium and process for preparation of the same
WO2011064793A1
Process for the preparation of amorphous valganciclovir hydrochloride
WO2011061761A2
Pharmaceutical composition for parenteral use comprising mycophenolate mofetil
WO2011051975A1
An improved process for the preparation of pure eprosartanand its pharmaceutical acceptable salts
WO2012020418A1
Novel polymorphs of 4-hydroxy atomoxetine hydrochloride
WO2010122576A1
Improved process for the preparation of 6-methyl-2-[4-methyl phenyl] imidazo [1, 2-a] pyridine-3-n, n-dimethyl acetamide.
EP2417150A2
An improved process for the preparation of desmopressin or its pharmaceutically acceptable salts
EP2414529A2
Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
WO2010035283A2
Novel compounds for producing substituted sulfoxides, process for producing the same and use thereof
